Phytopharm shares jumped 10.7% on the news, with analysts saying sales of $600m (Â£309m) a year were possible. Cactus diet deal for PhytopharmA slimming aid made from a southern African cactus is set to be developed by UK firm Phytopharm and Unilever. The plant, licensed to Phytopharm in 1997, has been used for thousands of years by the Sans bushmen of the Kalahari desert to stave off hunger. The firm had initially hoped to market a slimming drug from Hoodia with Pfizer. "This deal goes a long way to restoring the market faith in Phytopharm's pipeline after the Pfizer exit," said analyst Erling Refsum at Nomura.